NorthWest Biotherapeutics Inc (NWBO)

[meirluc]

"It is speculative to conclude that NWBO's decision to hold its annual meeting on December 29, 2025, and to increase authorized shares to 900 million is a sign of a substantial delay by the MHRA. The company has not publicly stated this reason, and there could be other business or financial reasons, such as funding future operations or a planned share offering, for these actions"

If the company is aware that the MHRA is substantially delaying its decision, wouldn't that
constitute "Material information" that should be divulged to the shareholders? The fact that
it has not been PRd, is also informative.